Challenges with participant reimbursement: experiences from a post-trial access study

, , , , , , , , &
Journal of Medical Ethics 41 (11):909-913 (2015)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1136/medethics-2013-101899

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,440

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Forthcoming practical framework for ethics committees and researchers on post-trial access to the trial intervention and healthcare.Neema Sofaer, Penney Lewis & Hugh Davies - 2014 - Journal of Medical Ethics 40 (4):217-218.
Care after research: a framework for NHS RECs.Neema Sofaer, Penney Lewis & Hugh Davies - 2012 - Health Research Authority.
Did we describe what you meant? Findings and methodological discussion of an empirical validation study for a systematic review of reasons.Marcel Mertz, Neema Sofaer & Daniel Strech - 2014 - BMC Medical Ethics 15 (1):69.
Mind the gap: An empirical study of post‐trial access in HIV biomedical prevention trials.Bridget Haire & Christopher Jordens - 2013 - Developing World Bioethics 15 (2):85-97.
Post-trial access to treatment: corporate best practices.Irene Schipper & Silvia Colona - 2015 - SOMO Centre for Research on Multinational Corporations.
More considerations on post-trial obligations in the Declaration of Helsinki 2013.Ignacio Mastroleo - manuscript
Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?Z. Zong - 2008 - Journal of Medical Ethics 34 (3):188-192.
Post-trial period surveillance for randomised controlled cardiovascular studies: submitted protocols, consent forms and the role of the ethics board.M. I. Zia, R. Heslegrave & G. E. Newton - 2011 - Journal of Medical Ethics 37 (12):762-765.
Reimbursement Decision-Making and Prescription Patterns of Glitazones in Treatment of Type 2 Diabetes Mellitus Patients in Denmark.P. B. Iversen & H. Vondeling - 2006 - Health Care Analysis 14 (2):79-89.
Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research.Sonia M. Dainesi & Moises Goldbaum - 2012 - Journal of Medical Ethics 38 (12):757-762.
EI principio de acceso posinvestigación en la revisión 2008 de la Declaración de Helsinki.Ignacio Mastroleo - 2008 - Perspectivas Bioéticas 13 (24-25):140-157.
Pharmaceutical Companies vs. the State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil?Daniel Wei L. Wang & Octavio Luiz Motta Ferraz - 2012 - Journal of Law, Medicine and Ethics 40 (2):188-196.
Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.N. Sofaer, C. Thiessen, S. D. Goold, J. Ballou, K. A. Getz, G. Koski, R. A. Krueger & J. S. Weissman - 2009 - Journal of Medical Ethics 35 (3):183-188.
Paying research participants: a study of current practices in Australia.C. L. Fry - 2005 - Journal of Medical Ethics 31 (9):542-547.
‘She's My Sister‐In‐Law, My Visitor, My Friend’ – Challenges of Staff Identity in Home Follow‐Up in an HIV Trial in W estern K enya.Philister Adhiambo Madiega, Gemma Jones, Ruth Jane Prince & Paul Wenzel Geissler - 2013 - Developing World Bioethics 13 (1):21-29.

Analytics

Added to PP
2015-12-02

Downloads
16 (#889,721)

6 months
2 (#1,229,212)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

Add more references